Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

MALDI-TOF Mass Spectrometry01:19

MALDI-TOF Mass Spectrometry

4.7K
Mass spectrometry is a powerful characterization technique that can identify and separate a wide variety of compounds ranging from chemical to biological entities, based on their mass-to-charge ratio (m/z). The instruments that allow this detection, known as mass spectrometers, have three components: an ion source, a mass analyzer, and a detector. These spectrometers differ based on the nature of their ion source and analyzers.
Matrix-assisted laser desorption ionization (MALDI) is a commonly...
4.7K
Serum Laboratory Studies, Stool Test, Breath Test01:30

Serum Laboratory Studies, Stool Test, Breath Test

313
Gastrointestinal (GI) diagnostic studies are pivotal in confirming, ruling out, diagnosing, or staging various diseases, including cancers. Following diagnosis, allocating time for discussions with the patient and providing informational resources is crucial. Diagnostic assessments of the GI tract often occur in outpatient settings like endoscopy suites or GI labs. Preparation for these tests may include dietary restrictions, fasting, liquid bowel preparations, laxatives, enemas, and the...
313
Key Techniques in Microbiology01:29

Key Techniques in Microbiology

Aseptic techniques prevent contamination, ensure experimental accuracy, and protect researchers and microbial cultures. These techniques are essential in clinical, industrial, and research settings where sterility is required.Maintaining Sterility in Laboratory PracticesScientists maintain sterility by sterilizing tools with heat or chemicals, disinfecting work surfaces, and handling cultures in controlled environments. Working near an open flame or within a laminar flow hood reduces the risk...

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Shifting the Timeline of Esophageal Adenocarcinoma: The Interplay of Lifestyle, Comedication, and Genetics.

United European gastroenterology journal·2026
Same author

Systematic assessment for potential endogenous normalizers for microRNA analysis in fecal samples.

Scientific reports·2026
Same author

The gut mycobiome is shaped by interactions with the bacterial community in twins.

iScience·2026
Same author

Combining tissue-derived microRNAs with clinical risk models for prediction of HCC recurrence after liver transplantation: A proof-of-concept study.

Scientific reports·2026
Same author

Circulating and faecal microRNAs as non-invasive biomarkers for IBD: current evidence and next steps.

Best practice & research. Clinical gastroenterology·2025
Same author

Single-cell insights into tumor microenvironment heterogeneity and plasticity: transforming precision therapy in gastrointestinal cancers.

Journal of experimental & clinical cancer research : CR·2025
Same journal

Bowel endometriosis: from pathogenesis to clinical management.

The lancet. Gastroenterology & hepatology·2026
Same journal

The Rome V criteria for the diagnosis of irritable bowel syndrome in secondary care: a diagnostic accuracy study.

The lancet. Gastroenterology & hepatology·2026
Same journal

The central role of primary care in liver health.

The lancet. Gastroenterology & hepatology·2026
Same journal

The role of primary care in response to the global liver disease syndemic: a Lancet Gastroenterology & Hepatology Commission.

The lancet. Gastroenterology & hepatology·2026
Same journal

Dupilumab versus placebo in adults and adolescents with eosinophilic gastritis (DEGAS): a double-blind, placebo-controlled, phase 2, multicentre, randomised controlled trial.

The lancet. Gastroenterology & hepatology·2026
Same journal

Addition of ipilimumab to atezolizumab plus bevacizumab in advanced hepatocellular carcinoma (PRODIGE 81-FFCD 2101-TRIPLET HCC): phase 2 results from a randomised, multicentre, open-label, phase 2-3 trial.

The lancet. Gastroenterology & hepatology·2026
查看所有相关文章

相关实验视频

Updated: Jun 5, 2025

Guided Protocol for Fecal Microbial Characterization by 16S rRNA-Amplicon Sequencing
08:05

Guided Protocol for Fecal Microbial Characterization by 16S rRNA-Amplicon Sequencing

Published on: March 19, 2018

19.6K

关于临床实践中的微生物组测试的国际共识声明.

Serena Porcari1, Benjamin H Mullish2, Francesco Asnicar3

  • 1Department of Translational Medicine and Surgery, Università Cattolica del Sacro Cuore, Rome, Italy; Department of Medical and Surgical Sciences, UOC Gastroenterologia, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy.

The lancet. Gastroenterology & hepatology
|December 8, 2024
PubMed
概括
此摘要是机器生成的。

肠道微生物组显示出诊断潜力,但缺乏临床证据. 专家建议标准化实践可靠的人类微生物组测试,以确保临床价值和防止资源浪费.

更多相关视频

Microbiota Analysis Using Two-step PCR and Next-generation 16S rRNA Gene Sequencing
11:22

Microbiota Analysis Using Two-step PCR and Next-generation 16S rRNA Gene Sequencing

Published on: October 15, 2019

27.8K
A Method for Targeted 16S Sequencing of Human Milk Samples
09:09

A Method for Targeted 16S Sequencing of Human Milk Samples

Published on: March 23, 2018

9.8K

相关实验视频

Last Updated: Jun 5, 2025

Guided Protocol for Fecal Microbial Characterization by 16S rRNA-Amplicon Sequencing
08:05

Guided Protocol for Fecal Microbial Characterization by 16S rRNA-Amplicon Sequencing

Published on: March 19, 2018

19.6K
Microbiota Analysis Using Two-step PCR and Next-generation 16S rRNA Gene Sequencing
11:22

Microbiota Analysis Using Two-step PCR and Next-generation 16S rRNA Gene Sequencing

Published on: October 15, 2019

27.8K
A Method for Targeted 16S Sequencing of Human Milk Samples
09:09

A Method for Targeted 16S Sequencing of Human Milk Samples

Published on: March 23, 2018

9.8K

科学领域:

  • 微生物组研究的研究.
  • 临床诊断 临床诊断 临床诊断
  • 医疗技术评估 医学技术评估

背景情况:

  • 越来越多的人对肠道微生物群对医学诊断的兴趣.
  • 有限的临床证据证明微生物组测试的有用性.
  • 不受监管的直接面向消费者的微生物组测试带来了资源浪费和临床管理不善的风险.

研究的目的:

  • 标准化微生物组测试临床实施的最佳实践.
  • 建立微生物组诊断的监管框架.
  • 尽量减少不适当的测试使用,并促进基于证据的开发.

主要方法:

  • 召集了一个国际多学科专家小组.
  • 制定了关于原则,要求,适应症,预测,分析,报告和临床价值的建议.
  • 评估当前的知识差距和未来的研究方向.

主要成果:

  • 建立了微生物组测试的标准化最佳实践.
  • 为规范微生物组诊断试验提供了一个框架.
  • 确定了未来研发的关键领域.

结论:

  • 标准化微生物组测试对于临床实施至关重要.
  • 需要一个监管框架来确保微生物组诊断的有效性和实用性.
  • 基于证据的开发将优化人类微生物组诊断在医学中的使用.